Scarica l'app Stockscreener
39.12
2.52%
0.96
Dopo l'orario di chiusura:
39.48
0.36
+0.92%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HROW Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$38.16
Aprire:
$38.36
Volume 24 ore:
618.31K
Relative Volume:
1.26
Capitalizzazione di mercato:
$1.45B
Reddito:
$154.15M
Utile/perdita netta:
$-33.58M
Rapporto P/E:
-40.75
EPS:
-0.96
Flusso di cassa netto:
$-20.74M
1 W Prestazione:
+0.77%
1M Prestazione:
+8.34%
6M Prestazione:
+35.13%
1 anno Prestazione:
-5.32%
Intervallo 1D:
$38.36
$40.41
Intervallo di 1 settimana:
$36.55
$40.41
Portata 52W:
$20.85
$59.23
Harrow Inc Stock (HROW) Company Profile
Nome
Harrow Inc
Settore
Telefono
615.733.4731
Indirizzo
1A BURTON HILLS BLVD, NASHVILLE, CA
Confronta HROW con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
39.12 | 1.42B | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
156.62 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.52 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.82 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.46 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
312.23 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-11 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-06-12 | Iniziato | BTIG Research | Buy |
| 2025-06-10 | Iniziato | William Blair | Outperform |
| 2025-02-06 | Iniziato | H.C. Wainwright | Buy |
| 2024-12-04 | Reiterato | B. Riley Securities | Buy |
| 2024-04-11 | Iniziato | Craig Hallum | Buy |
| 2022-09-08 | Ripresa | B. Riley Securities | Buy |
| 2021-10-14 | Ripresa | B. Riley Securities | Buy |
| 2021-09-24 | Iniziato | Aegis Capital | Buy |
| 2021-07-02 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Harrow Inc Borsa (HROW) Ultime notizie
MACD Cross Could Confirm Trend in Harrow Inc.July 2025 Reactions & Technical Pattern Recognition Alerts - thegnnews.com
Intraday Charts Show Spike in Harrow Inc. ActivityTrade Signal Summary & Proven Capital Preservation Tips - newsimpact.co.kr
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW - FinancialContent
Harrow Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Harrow jumps as Cantor initiates with Bullish view on conservative outlook - MSN
What’s the outlook for Harrow Inc.’s sectorPortfolio Risk Summary & AI Powered Trade Plan Recommendations - classian.co.kr
Real time alert setup for Harrow Inc. performance2025 Price Action Summary & Fast Entry Momentum Alerts - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc.HROW - cnhinews.com
Best Momentum Stock to Buy for August 15th - MSN
Forecasting Harrow Inc. price range with options data2025 Top Gainers & Daily Volume Surge Signals - Newser
What makes Harrow Inc. stock price move sharply2025 Price Momentum & Long-Term Investment Growth Plans - thegnnews.com
What indicators show strength in Harrow Inc.2025 Dividend Review & Breakout Confirmation Trade Signals - Newser
Surging Earnings Estimates Signal Upside for Harrow (HROW) Stock - Yahoo Finance
Wall Street Analysts Think Harrow (HROW) Could Surge 53.24%: Read This Before Placing a Bet - Yahoo Finance
Can Harrow Inc. deliver consistent EPS growthTrade Signal Summary & Reliable Intraday Trade Alerts - newsyoung.net
Does Harrow Inc. fit your quant trading modelWeekly Profit Analysis & Technical Buy Zone Confirmations - Newser
Byooviz US Launch Slated For 2026 As Harrow Touts Immediate Uptake Potential - insights.citeline.com
Is Harrow's (HROW) Expanding Ophthalmic Pipeline Strengthening Its Long-Term Market Position? - simplywall.st
Harrow's Ambitious Guidance Puts It In The Proving Ground - Seeking Alpha
Momentum Traders Eye Harrow Inc. for Quick BounceWeekly Stock Analysis & Community Trade Idea Sharing - thegnnews.com
Harrow Surprises Market: A New Peak Insight? - timothysykes.com
Harrow, Inc. (HROW) and the Implications of Its Rising Relative Strength Rating: A Sustainable Turnaround in the Ophthalmic Sector? - AInvest
Harrow: Q2 Earnings Snapshot - Local 3 News
Harrow: Exciting Times In Store (NASDAQ:HROW) - Seeking Alpha
Missing your fill of dill without Bick's? Meet Essex County's own longtime pickle packer - CBC
Harrow Health, Inc. (NASDAQ:HROW) Q2 2025 Earnings Call Transcript - Insider Monkey
HROW: HC Wainwright & Co. Raises Price Target, Maintains Buy Rat - GuruFocus
Harrow, Inc. shares rise 2.15% premarket after Q2 2025 earnings call. - AInvest
Harrow Inc (HROW) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansions By GuruFocus - Investing.com Canada
Harrow Health Reports Strong Q2 2025 Financial Results - TipRanks
Harrow, Inc. shares rise 2.50% after-hours after reporting Q2 earnings that surpassed Wall Street expectations. - AInvest
Harrow, Inc. Q2 2025 Earnings: A Catalyst for Long-Term Ophthalmic Growth - AInvest
Why Harrow Inc. stock attracts strong analyst attentionPowerful ROI Trade Ideas - thegnnews.com
Transcript : Harrow, Inc., Q2 2025 Earnings Call, Aug 12, 2025 - MarketScreener
Harrow, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:HROW) - Seeking Alpha
A Preview Of Harrow's Earnings - 富途牛牛
Earnings call transcript: Harrow Health beats EPS expectations in Q2 2025 - Investing.com
Harrow Announces Second-Quarter 2025 Financial Results - GlobeNewswire
Harrow Health’s Growth Streak Sets High Hopes For 2025 - Finimize
Harrow Swings to Q2 Earnings, Revenue Jumps - MarketScreener
Earnings Flash (HROW) Harrow, Inc. Posts Q2 Diluted EPS $0.24 per Share - MarketScreener
Earnings Flash (HROW) Harrow, Inc. Reports Q2 Revenue $63.7M, vs. FactSet Est of $66.0M - MarketScreener
Harrow Inc (HROW) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Will Harrow's (HROW) Recent Conference Engagements Reveal More About Its Competitive Position? - simplywall.st
Harrow Inc Q2 2025 Earnings Report Preview: Revenue, Earnings, and Price Targets - AInvest
Harrow 8.625% 20260430 HROWL Q2 2025 Earnings Preview Upside Anticipated on Strong Educational Expansion - AInvest
Harrow, Inc. shares fall 1.82% intraday after announcing participation in H.C. Wainwright’s 5th Annual Ophthalmology Conference. - AInvest
Harrow to Present at H.C. Wainwright 5th Annual Ophthalmology Co - GuruFocus
Harrow to Present at H.C. Wainwright 5th Annual Ophthalmology Conference - The Manila Times
Harrow Inc Azioni (HROW) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Harrow Inc Azioni (HROW) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
Jun 10 '25 |
Sale |
30.80 |
15,000 |
462,033 |
90,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 09 '25 |
Sale |
30.37 |
15,204 |
461,794 |
105,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 03 '25 |
Sale |
30.04 |
3,000 |
90,116 |
122,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 04 '25 |
Sale |
30.02 |
1,796 |
53,907 |
120,204 |
| Opaleye Management Inc. | 10% Owner |
May 12 '25 |
Sale |
25.90 |
10,000 |
258,959 |
130,000 |
| Opaleye Management Inc. | 10% Owner |
May 13 '25 |
Sale |
26.59 |
5,000 |
132,945 |
125,000 |
| BOLL ANDREW R. | Chief Financial Officer |
Apr 03 '25 |
Option Exercise |
0.00 |
346,500 |
0 |
914,589 |
| SAHAREK JOHN P. | CEO & President, ImprimisRx |
Apr 03 '25 |
Option Exercise |
0.00 |
277,200 |
0 |
576,863 |
| BAUM MARK L | Chief Executive Officer |
Apr 03 '25 |
Option Exercise |
0.00 |
762,300 |
0 |
2,899,825 |
| Opaleye Management Inc. | 10% Owner |
Mar 18 '25 |
Sale |
30.01 |
5,000 |
150,055 |
140,000 |
2.37%
0.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):